ClinicalTrials.gg
CompletedNCT05860985RESIGHTUpdated Aug 26, 2024

Zeiss RESIGHT Disposable Lenses Evaluation Study

An interventional study of ZEISS disposable in Retinal Detachment, Macular Pucker and Macular Holes, sponsored by Universitaire Ziekenhuizen KU Leuven. Completed at 1 site in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-26.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

To evaluate the intra-operative efficacy of a new intra-operative viewing device.

Read the detailed description

This study is designed to obtain more information on the efficacy of the disposable RESIGHT lenses in routine vitrectomy surgery. This information can lead to adjustments to these surgical lenses to further fine tune a device which can be used by other surgeons.

Theoretically, both the improved lens design and better resistance to fogging should improve the visualization of the retina hence facilitate the surgery, increasing the surgical safety.

02

Conditions studied

  • Retinal Detachment
  • Macular Pucker
  • Macular Holes
  • Vitreomacular Traction
03

In context

Retinal Detachment

199 studies on the registry are indexed under Retinal Detachment; 29 are open to participants now.

This study's enrollment of 120 is above the median of 50 across 132 interventional studies indexed under Retinal Detachment.

Browse Retinal Detachment studies →

Lead sponsor

Universitaire Ziekenhuizen KU Leuven is the lead sponsor of 963 studies on the registry; 267 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Voluntary written of the participant or their legally authorized representative has been obtained prior to any screening procedures
  • Patients that are scheduled for primary vitrectomy surgery to treat retinal detachment or macular disease (pucker, macular hole, vitreomacular traction).
  • Both vitrectomy-only and combined phaco-vitrectomy surgeries
  • General or local anesthesia, or combination

Exclusion criteria

Exclusion Criteria:

  • Patient who do not have sufficient command of the Dutch language to read and understand the form
  • Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CIP.
  • Repeat vitrectomy surgery
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Active comparator
    group 1

    primary vitrectomy surgery for retinal detachment

    Device: ZEISS disposable

  • Active comparator
    group 2

    macular surgery: pucker, vitreomacular traction or macular hole

    Device: ZEISS disposable

Interventions

  • DeviceZEISS disposable

    a comparison will be done between the present lenses used (reusable RESIGHT lenses and disposable Vitreq contact lens) and the new disposable RESIGHT lenses.

06

What researchers measure

Primary outcomes

  1. Ultra Wide Field lens View Angle evaluation

    Ultra Wide Field lens View Angle: scale from 1 (far more indentation) to 5 (far less indentation)

    Time frame: during surgery

  2. Ultra Wide Field lens Condensation evaluation

    Ultra Wide Field lens Condensation: scale from 1 (far more condensation) to 5 (far less condensation)

    Time frame: during surgery

  3. Wide Angle lens Condensation evaluation

    Wide Angle lens Condensation: scale from 1 (far more condensation ) to 5 (far less condensation)

    Time frame: during surgery

  4. Illumination appearance evaluation

    Illumination intensity required during the surgery : scale from 1 (significantly higher) to 5 (significantly lower)

    Time frame: during surgery

  5. Color appearance evaluation

    color appearance during the surgery : scale from 1 (far less natural colors) to 5 (far better natural colors )

    Time frame: during surgery

07

Study locations

1 site
  • Universitaire Ziekenhuizen Leuven
    Leuven, Vlaams-Brabant 3000, Belgium
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05860985
Responsible party
Sponsor
First posted
May 16, 2023
Start date
Apr 11, 2023
Primary completion
Jul 1, 2024
Completion
Jul 31, 2024
Last update
Aug 26, 2024

Study contacts

Peter Stalmans, PhD, MD
principal investigator · UZ Leuven

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion